Bioinformatic analysis reveals prognostic value and immunotherapy potential of Siglec-15 in laryngeal squamous cell carcinoma [PDF]
Background: Laryngeal squamous cell carcinoma (LSCC) is the ultimate common malignant head and neck cancer with dismal prognosis. The expression pattern and clinical significance of Siglec-15 (Sialic acid-binding immunoglobulin-like lectin 15) in LSCC ...
Xiaoting Chen +4 more
doaj +2 more sources
Anti‐Siglec‐15 Antibody Prevents Marked Bone Loss after Acute Spinal Cord Injury‐Induced Immobilization in Rats [PDF]
Rapid and extensive sublesional bone loss after spinal cord injury (SCI) is a difficult medical problem that has been refractory to available interventions except the antiresorptive agent denosumab (DMAB). While DMAB has shown some efficacy in inhibiting
Yuanzhen Peng +13 more
doaj +2 more sources
Development of a Novel Anti-Siglec-15 Antibody for Tumor Immunotherapy [PDF]
Qin Liu,1,* Lin Li,1,* Siji Nian,1 Xiaoke Sun,2 Xiyuan Guo,1 Chengwen Li,1 Zhihui Yang,3 Yingchun Ye,1 Qing Yuan1,4 1Public Center of Experimental Technology, The School of Basic Medical Sciences, Southwest Medical University, Luzhou ...
Liu Q +8 more
doaj +2 more sources
Killing two birds with one stone: Siglec-15 targeting integrated bioactive glasses hydrogel for treatment of breast cancer bone metastasis [PDF]
Bone metastasis is a fatal consequence of breast cancer that occurs when patients fail to respond to conventional therapies and mainly result from a vicious cycle involving dysregulated bone homeostasis and uncontrolled tumor growth.
Chengkuan Liu +6 more
doaj +2 more sources
Involvement of Siglec-15 in regulating RAP1/RAC signaling in cytoskeletal remodeling in osteoclasts mediated by macrophage colony-stimulating factor [PDF]
DNAX-associated protein 12 kD size (DAP12) is a dominant immunoreceptor tyrosine-based activation motif (ITAM)-signaling adaptor that activates costimulatory signals essential for osteoclastogenesis.
Hideyuki Kobayashi +11 more
doaj +2 more sources
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec‐15 axis in immune escape [PDF]
Background Metabolic reprograming and immune escape are two hallmarks of cancer. However, how metabolic disorders drive immune escape in head and neck squamous cell carcinoma (HNSCC) remains unclear.
Xin‐Yu Zhang +7 more
doaj +2 more sources
Background. Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death, and its biology remains poorly understood, especially in regards to the immunosuppression induced by immune checkpoints, such as Siglec-15.
Yanyi Ren +4 more
doaj +2 more sources
Development of an immunohistochemical assay for Siglec-15. [PDF]
Siglec-15, a member of sialic-acid binding immunoglobulin type lectins, is normally expressed by myeloid cells and upregulated in some human cancers and represents a promising new target for immunotherapy.
Shafi S +17 more
europepmc +4 more sources
Transcriptional Regulation of Siglec-15 by ETS-1 and ETS-2 in Hepatocellular Carcinoma Cells. [PDF]
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) has been identified as a crucial immune suppressor in human cancers, comparable to programmed cell death 1 ligand (PD-L1).
Sheng K +6 more
europepmc +2 more sources
Anti-Tumor Activities of Anti-Siglec-15 Chimeric Heavy-Chain Antibodies. [PDF]
Immune checkpoint inhibitors like programmed cell death 1 (PD-1) antibodies have revolutionized cancer treatment, but patient response rates remain limited.
Cheng K +7 more
europepmc +2 more sources

